Phenomenex Launches Chiral Screening Service

25-Mar-2010 - USA

Phenomenex Inc. announces a Chiral Screening Service for customers in pharmaceutical and natural products research and development. This free service provides target screening using a library of HPLC and SFC columns including the Phenomenex Lux polysaccharide-based offerings. After resolving the chiral compound, Phenomenex also produces method development and optimization for the service customer, all within 10 business days.

Enantiomers of chiral compounds may have different pharmacological effects in biological systems. Regulations require that enantiomers of all chiral drugs in development be screened separately on their pharmacodynamic and pharmacokinetic properties.

"Resolving chiral compounds is relatively difficult, and column selection can be complicated," explained Kari Carlson, brand manager for Phenomenex. "Our Chiral Screening Service eliminates time-consuming guesswork and also gives customers a chance to 'test-drive' our Lux columns."

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!

See the theme worlds for related content

Topic World Chromatography

Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!

50+ products
20+ whitepaper
40+ brochures
View topic world

Topic World Chromatography

Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!

50+ products
20+ whitepaper
40+ brochures